The growing number of private biopharma and diagnostic/therapeutic technology company financings completed in recent months masks an overall year-over-year decrease in the total value of those deals.
{iframe}https://www.genengnews.com/a-lists/top-10-young-companies-in-the-money-january-july-2019/?utm_medium=newsletter&utm_source=GEN+Daily+News+Highlights&utm_content=01&utm_campaign=GEN+Daily+News+Highlights_20190806&oly_enc_id=1673D8247356B7U{/iframe}